Oppenheimer Asset Management Inc. Repligen Corp Transaction History
Oppenheimer Asset Management Inc.
- $7.94 Billion
- Q4 2024
A detailed history of Oppenheimer Asset Management Inc. transactions in Repligen Corp stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 17,567 shares of RGEN stock, worth $2.74 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
17,567
Previous 20,985
16.29%
Holding current value
$2.74 Million
Previous $3.12 Million
19.03%
% of portfolio
0.03%
Previous 0.04%
Shares
27 transactions
Others Institutions Holding RGEN
# of Institutions
477Shares Held
54.9MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.18 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$997 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$787 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$253 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$222 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.66B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....